ARCHIVES

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

This article is from The Cancer Letter archive.

Vol. 34 No. 18 | May 9, 2008

Download PDF Visit The Full Archive

Related Articles

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

European Commission Approves Subcutaneous Rituximab

March 28, 2014

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005

Cure For Lymphoma Foundation Awards Five; Lefall Honored; AACR Begins New Journal.

November 23, 2001

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977